Imaging agents

Details Imaging agents Imaging agents

2006-06-19

2010-11-23

Jones, D L (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S001110, C424S001650, C424S001810, C424S001850, C424S009100, C424S009400

Reexamination Certificate

active

07837982

ABSTRACT:
The present invention provides novel amino acid compounds useful in detecting and evaluating brain and body tumors. These compounds have the advantageous properties of rapid uptake and prolonged retention in tumors and can be labeled with halogen isotopes such as fluorine-18, iodine-123, iodine-124, iodine-125, iodine-131, bromine-75, bromine-76, bromine-77, bromine-82, astatine-210, astatine-211, and other astatine isotopes. These compounds can also be labeled with technetium and rhenium isotopes using known chelation complexes. The compounds disclosed herein bind tumor tissues in vivo with high specificity and selectivity when administered to a subject. Preferred compounds show a target to non-target ratio of at least 2:1, are stable in vivo and substantially localized to target within 1 hour after administration. Preferred compounds include 1-amino-2-[18F]fluorocyclobutyl-1-carboxylic acid (2-[18F]FACBC) and 1-amino-2-[18F]fluoromethylcyclobutyl-1-carboxylic acid (2-[18F]FMACBC). The labeled amino acid compounds of the invention are useful as imaging agents in detecting and/or monitoring tumors in a subject by PET or SPECT.

REFERENCES:
patent: 3855208 (1974-12-01), Rutner et al.
patent: 4325961 (1982-04-01), Kollonitsch et al.
patent: 4358434 (1982-11-01), Tzodikov et al.
patent: 4390517 (1983-06-01), O'Brien et al.
patent: 4483870 (1984-11-01), Kollonitsch et al.
patent: 4695588 (1987-09-01), Kollonitsch et al.
patent: 4743691 (1988-05-01), Bey et al.
patent: 4760091 (1988-07-01), Carson et al.
patent: 4942231 (1990-07-01), Mertens
patent: 5227467 (1993-07-01), Durette et al.
patent: 5279812 (1994-01-01), Krstenansky et al.
patent: 5310912 (1994-05-01), Neumeyer et al.
patent: 5324504 (1994-06-01), Roger, Jr. et al.
patent: 5413779 (1995-05-01), Kuhar et al.
patent: 5637759 (1997-06-01), Hearst et al.
patent: 5698179 (1997-12-01), Neumeyer et al.
patent: 5773614 (1998-06-01), Godfrey et al.
patent: 5808146 (1998-09-01), Goodman et al.
patent: 5817776 (1998-10-01), Goodman et al.
patent: 5853696 (1998-12-01), Elmaleh et al.
patent: 6096874 (2000-08-01), Wallace et al.
patent: 6245326 (2001-06-01), Topping et al.
patent: 6344179 (2002-02-01), Goodman
patent: 6399042 (2002-06-01), Goodman
patent: 2002/0099184 (2002-07-01), Goodman et al.
patent: 2005/0085545 (2005-04-01), Susacca et al.
patent: 2005/0130274 (2005-06-01), O'Hagan et al.
patent: 2005/0159790 (2005-07-01), Shalev
patent: 2005/0192458 (2005-09-01), Goodman et al.
patent: 2005/0197350 (2005-09-01), Sekiguchi et al.
patent: 2005/0226776 (2005-10-01), Brandy et al.
patent: 2006/0292073 (2006-12-01), Goodman et al.
patent: 2007/0082879 (2007-04-01), Goodman et al.
patent: 1 464 335 (2004-10-01), None
patent: WO 97/17092 (1997-05-01), None
patent: WO 97/43285 (1997-11-01), None
patent: WO 99/01149 (1999-01-01), None
patent: WO 02/00209 (2002-01-01), None
patent: WO 03/078358 (2003-09-01), None
patent: WO 03/093412 (2003-11-01), None
patent: WO 2004/056725 (2004-07-01), None
patent: WO 2005/021485 (2005-03-01), None
patent: WO 2005/030025 (2005-04-01), None
patent: WO 2005/030677 (2005-04-01), None
patent: WO 2005/051384 (2005-06-01), None
patent: WO 2005/061110 (2005-07-01), None
Martarello et al (2002), Journal of Medicinal Chemistry, 2002, vol. 45(11), pp. 2250-2259.
International Search Report, International Application No. PCT/US06/23699, mailed Apr. 5, 2007, 2 pages.
Alexoff et al. (1992) “Ion Chromatographic Analysis of High Specific Activity18FDG Preparations and Detection of the Chemical Impurity 2-Deoxy-2-chloro-D-Glucose,”Int. J. Rad. Instr. Part. A43(11):1313-1322.
Berge et al. (1977) “Pharmaceutical Salts,”J. Pharm. Sci.66:1-19.
Bergmann et al. (1962) “Organic Fluorine Compounds Part XXVII. Fluorinated α-Aminoisobutyric Acids,”J. Chem. Soc.:3462-3463.
Betz et al. (1978) “Polarity of the Blood-Brain Barrier: Neutral Amino Acid Transport into Isolated Brain Capillaries,”Science202:225-227.
Bey et al. (1979) “Direct Synthesis of Alpha-Halogenomethyl-Alpha-Amino Acids from the Parent Alpha-Amino Acids,”J. Org. Chem. 44:15:2732-2742.
Blough et al. (1996) “Synthesis and Transporter Binding Properties of 3β-(4′-Alkyl-, 4′A;kenyl-, and 4′Alkynylphenyl)nortropane-2β-Carboxylic Acid Methyl Esters: Serotonin Transporter Selective Analogs,”J. Med. Chem. 39(20):4027-4035.
Blough et al. (1997) “3β-(4-Ethyl-3-iodophenyl)nortropane-2β-carboxylic Acid Methyl Ester as a High-Affinity Selective Ligand for the Serotonin Transporter”J. Med. Chem. 40(24):3861-3864.
Bodsch et al. (1988) “Biochemical and Autoradiographic Study of Cerebral Protein Synthesis with Fluorine-18 Fluorophenylalanine and Carbon-14 Fluorophenylalanine,”J. Neurochem. 50(3):979-983.
Boger et al. (1992) “Functional Analogs of CC-1065 and the Duocarmycins Incorporating the 9a-(chloorormethyl—-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (C2BI) Alkylation Subunit: Synthesis and Preliminary DNA Alylaation Studies,”J. Am. Chem. Soc. 114:9318-9327.
Buonocore, E (1992) “Comparison of PET with Conventional Imaging Techniques,”Clinical Positron Emission Tomography, Mosby-Year Book Inc. St. Louis, MO, pp. 17-22.
Bussolati et al. (1996) “The Stimulation of Na, K, CI Cotransport and of System A for Neutral Amino Acid Transport is a Mechanism for Cell Colume Increase During the Cell Cycle,”FASB J. 10:920-926.
Chiotellis et al. (1977) “Preparation of Tc-99m Labeled Pyridoxal-Amino-Acid Complexes and Their Ecaluation,”Int. J. Nuc. Med. Biol. 4(1):29-41 and CA 1977:498177.
Christensen et al. (1983) “Synthesis and Transport Applications of 3-Aminobicuclo[3.2.1]Octane-3-carboxylic Acids,”J. Med. Chem. 16:1374-1378.
Christensen et al. (Sep. 1965) “The Use of N-Methylation to Direct the Route of Mediated Transport of Amino Acids,”J. Biol. Chem. 240(9):3609-3616.
Coleman, RE. (1991) “Single Photon Emission Computed Tomography and Positron Emission Tomography in Cancer Imaging,”Cancer67(4 supp.):1261-1270.
Conti et al. (1986) “Tumor Imaging with Carbon-11 Labeled Alpha-Aminoisobutyric Acid (AIB) in a Patient with Advances Malignant Melanoma,”Eur. J. Nuc. Med. 12:353-356.
Conti, PS (1995) “Introduction to Imaging Brain Tumor Metabolism with Positron Emission Tomography (PET),”Cancer Invest. 13(2):244-259.
Conti et al. (1985) “Tumor Localization of Alpha-Aminoisobutyric Acid (AIB) in Human Melanoma Heterotransplants,”Eur. J. Nuc. Med. 10:45-47.
Damhaut et al. (1997) “No-Carrier-Added Asymmetric Synthesis of Alpha-Methyl-Alpha-Amino Acids Labelled with Fluorine-18,”Tetrahedron53(16):5785-5796.
Di Chiro et al. (1982) “Glucose Utilization of Cerebral Gliomas Measured γ[18F] Fluorodeoxyglucose and Positron Emission Tomography,”Neurology32:1323-1329.
Dunzendorfer et al. (1981) “Synthesis and Body Distribution of Alpha-Aminoisobutyric Acid-L-11C in Normal and Prostate Cancer-Bearing Rat After Chemotherapy,”Eur. J. Nuc. Med. 6:535-538.
Dutta et al. (1996) “Structure-Activity Relationship Studies of Novel 4-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-1-(3-phenylpropyl-piperidine) Analogs: Synthesis and Biological Evaluation at the Dopamine and Serotonin Transporter Sites,”J. Med. Chem. 39:749-756.
Feinendegen, LE (1993), “Contributions of Nuclear Medicine to the Therapy of Malignant Tumors (editorial),”J. Can. Res. Clin. Oncol. 119(6):320-322.
Finar (1973)Organic Chemistry, vol. 1,The Fundamental Principles, 6thed., pp. 61-62.
Fishman et al. “SPECT Imaging of Dopamine Transporter Sites in Normal and MPTP-Treated Rhesus Monkeys” (1997)J. Nucl. Med. 38:144-150.
Giros et al. (1996) “Hyperlocomotion and Indifference to Cocaine and Amphetamine in Mice Lacking the Dopamine Transporter”Nature379:606-612.
Goodman et al. (1994) “Synthesis and Characterization of Radioiodinated N-(3-l

Affiliated with

Also associated with

Rating

Imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imaging agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4242000